Pertuzumab and trastuzumab combination improved efficacy for women with HER2-positive breast cancer
Friday, December 10, 2010 - 10:00
in Health & Medicine
The combination of pertuzumab and trastuzumab had superior antitumor activity in women with early HER2-positive breast cancer, according to Phase II study results of the NeoSphere neoadjuvant trial.